These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7520717)

  • 1. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.
    Laaroubi K; Delbé J; Vacherot F; Desgranges P; Tardieu M; Jaye M; Barritault D; Courty J
    Growth Factors; 1994; 10(2):89-98. PubMed ID: 7520717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
    Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
    J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and mitogenic properties of the heparin-binding growth factor HARP.
    Laaroubi K; Vacherot F; Delbé J; Caruelle D; Barritault D; Courty J
    Prog Growth Factor Res; 1995; 6(1):25-34. PubMed ID: 8714367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities.
    Bernard-Pierrot I; Delbe J; Caruelle D; Barritault D; Courty J; Milhiet PE
    J Biol Chem; 2001 Apr; 276(15):12228-34. PubMed ID: 11150308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides.
    Papadimitriou E; Heroult M; Courty J; Polykratis A; Stergiou C; Katsoris P
    Biochem Biophys Res Commun; 2000 Jul; 274(1):242-8. PubMed ID: 10903925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
    Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion and biological activities of heparin-binding growth-associated molecule. Neurite outgrowth-promoting and mitogenic actions of the recombinant and tissue-derived protein.
    Raulo E; Julkunen I; Merenmies J; Pihlaskari R; Rauvala H
    J Biol Chem; 1992 Jun; 267(16):11408-16. PubMed ID: 1597470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.
    Hamma-Kourbali Y; Bermek O; Bernard-Pierrot I; Karaky R; Martel-Renoir D; Frechault S; Courty J; Delbé J
    BMC Cancer; 2011 May; 11():212. PubMed ID: 21624116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities.
    Bernard-Pierrot I; Delbé J; Rouet V; Vigny M; Kerros ME; Caruelle D; Raulais D; Barritault D; Courty J; Milhiet PE
    J Biol Chem; 2002 Aug; 277(35):32071-7. PubMed ID: 12070152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implication of HARP in angiogenesis and possible therapeutic role].
    Delbe J; Katsoris P; Milhiet PE; Barritault D; Caruelle D; Courty J
    Pathol Biol (Paris); 1999 Apr; 47(4):352-7. PubMed ID: 10372404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of heparin affin regulatory peptide in human prostate cancer.
    Vacherot F; Caruelle D; Chopin D; Gil-Diez S; Barritault D; Caruelle JP; Courty J
    Prostate; 1999 Feb; 38(2):126-36. PubMed ID: 9973098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide.
    Dos Santos C; Blanc C; Elahouel R; Prescott M; Carpentier G; Ori A; Courty J; Hamma-Kourbali Y; Fernig DG; Delbé J
    Biochimie; 2014 Dec; 107 Pt B():350-7. PubMed ID: 25315978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosaminoglycans promote HARP/PTN dimerization.
    Bernard-Pierrot I; Héroult M; Lemaître G; Barritault D; Courty J; Milhiet PE
    Biochem Biophys Res Commun; 1999 Dec; 266(2):437-42. PubMed ID: 10600521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
    Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human heparin-binding neurite-promoting factor expressed with yeast stimulates neurites outgrowth.
    Wang Y; Chen Z; Chen Z; Guan X; Song H; Wu X; Liu Y
    Chin Med J (Engl); 2002 Sep; 115(9):1352-7. PubMed ID: 12411111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity.
    Li YS; Milner PG; Chauhan AK; Watson MA; Hoffman RM; Kodner CM; Milbrandt J; Deuel TF
    Science; 1990 Dec; 250(4988):1690-4. PubMed ID: 2270483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.
    Dean RA; Butler GS; Hamma-Kourbali Y; Delbé J; Brigstock DR; Courty J; Overall CM
    Mol Cell Biol; 2007 Dec; 27(24):8454-65. PubMed ID: 17908800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.